|
|
|
07/06/2010
Action Pharma obtains encouraging preliminary results in a phase II clinical trial with AP214
 Read more »
03/06/2010
Action Pharma completes EUR 5 million financing round to advance its lead project AP214
Read more »
08/04/2010
AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH® Protocol for Identifying Candida Bloodstream Pathogens
Read more »
24/03/2010
Action Pharma focuses its strategy and appoints a new CEO
Read more »
08/03/2010
Action Pharma reports positive results in a proof of concept phase IB study in obese human volunteers treated with small molecule oral once-daily AP1030 targeted for type II diabetes associated with obesity
Read more »
11/02/2010
Frost & Sullivan Recognizes Doxa AB for Ceramir® Crown & Bridge, its Pioneering Biocompatible Dental Cement
Read more »
01/02/2010
Göran Beijer new CEO at ONCOlog Medical QA AB in Uppsala, Sweden
Read more »
29/01/2010
Siemens chooses ONCOlog Medical DIGNITY Carrier for PET/CT
Read more »
|
